title: Truncated form of beta-catenin and reduced expression of wild-type catenins feature HepG2 human liver cancer cells.
authors.affiliation: Institute of Oncology, University of Palermo, Italy. lucashbl@unipa.it
authors.forename: G
authors.initials: G
authors.lastname: Carruba
authors.forename: M
authors.initials: M
authors.lastname: Cervello
authors.forename: M D
authors.initials: MD
authors.lastname: Miceli
authors.forename: R
authors.initials: R
authors.lastname: Farruggio
authors.forename: M
authors.initials: M
authors.lastname: Notarbartolo
authors.forename: L
authors.initials: L
authors.lastname: Virruso
authors.forename: L
authors.initials: L
authors.lastname: Giannitrapani
authors.forename: R
authors.initials: R
authors.lastname: Gambino
authors.forename: G
authors.initials: G
authors.lastname: Montalto
authors.forename: L
authors.initials: L
authors.lastname: Castagnetta
mesh_terms: D006528:Carcinoma, Hepatocellular / Q000235:genetics* / Q000473:pathology; D003598:Cytoskeletal Proteins / Q000235:genetics*; D006801:Humans; D008113:Liver Neoplasms / Q000235:genetics* / Q000473:pathology; D015534:Trans-Activators; D051176:beta Catenin
chemical_list: C495270:CTNNB1 protein, human; D003598:Cytoskeletal Proteins; D015534:Trans-Activators; D051176:beta Catenin